|
Name |
12E,15R-5-hydroxy-3-methoxy-16-methyl-8,9,10,11,14,15-hexahydro-1H-benzo[c][1]oxacyclodocecin-1-one
|
| Molecular Formula | C17H22O4 | |
| IUPAC Name* |
(4R,6E)-14-hydroxy-16-methoxy-4-methyl-3-oxabicyclo[10.4.0]hexadeca-1(12),6,13,15-tetraen-2-one
|
|
| SMILES |
C[C@@H]1C/C=C/CCCCC2=C(C(=CC(=C2)O)OC)C(=O)O1
|
|
| InChI |
InChI=1S/C17H22O4/c1-12-8-6-4-3-5-7-9-13-10-14(18)11-15(20-2)16(13)17(19)21-12/h4,6,10-12,18H,3,5,7-9H2,1-2H3/b6-4+/t12-/m1/s1
|
|
| InChIKey |
MRKJWGWVFJOTLX-FVOPLDGLSA-N
|
|
| Synonyms |
12E,15R-5-hydroxy-3-methoxy-16-methyl-8,9,10,11,14,15-hexahydro-1H-benzo[c][1]oxacyclodocecin-1-one
|
|
| CAS | NA | |
| PubChem CID | 139591595 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 290.4 | ALogp: | 4.3 |
| HBD: | 1 | HBA: | 4 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 55.8 | Aromatic Rings: | 2 |
| Heavy Atoms: | 21 | QED Weighted: | 0.618 |
| Caco-2 Permeability: | -4.733 | MDCK Permeability: | 0.00003270 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.15 |
| 30% Bioavailability (F30%): | 0.673 |
| Blood-Brain-Barrier Penetration (BBB): | 0.099 | Plasma Protein Binding (PPB): | 98.63% |
| Volume Distribution (VD): | 1.372 | Fu: | 1.36% |
| CYP1A2-inhibitor: | 0.972 | CYP1A2-substrate: | 0.697 |
| CYP2C19-inhibitor: | 0.928 | CYP2C19-substrate: | 0.28 |
| CYP2C9-inhibitor: | 0.74 | CYP2C9-substrate: | 0.97 |
| CYP2D6-inhibitor: | 0.935 | CYP2D6-substrate: | 0.889 |
| CYP3A4-inhibitor: | 0.699 | CYP3A4-substrate: | 0.096 |
| Clearance (CL): | 5.357 | Half-life (T1/2): | 0.823 |
| hERG Blockers: | 0.028 | Human Hepatotoxicity (H-HT): | 0.192 |
| Drug-inuced Liver Injury (DILI): | 0.331 | AMES Toxicity: | 0.015 |
| Rat Oral Acute Toxicity: | 0.008 | Maximum Recommended Daily Dose: | 0.918 |
| Skin Sensitization: | 0.938 | Carcinogencity: | 0.163 |
| Eye Corrosion: | 0.024 | Eye Irritation: | 0.817 |
| Respiratory Toxicity: | 0.275 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002298 | ![]() |
0.662 | D07MGA | ![]() |
0.304 | ||
| ENC005004 | ![]() |
0.662 | D0J4IX | ![]() |
0.287 | ||
| ENC005006 | ![]() |
0.644 | D0L1JW | ![]() |
0.287 | ||
| ENC005001 | ![]() |
0.644 | D03SKD | ![]() |
0.278 | ||
| ENC002425 | ![]() |
0.639 | D0X5KF | ![]() |
0.271 | ||
| ENC003715 | ![]() |
0.622 | D09PJX | ![]() |
0.255 | ||
| ENC002387 | ![]() |
0.587 | D0R9VR | ![]() |
0.253 | ||
| ENC003318 | ![]() |
0.556 | D02LZB | ![]() |
0.252 | ||
| ENC002946 | ![]() |
0.494 | D04TDQ | ![]() |
0.252 | ||
| ENC005476 | ![]() |
0.494 | D0G4YT | ![]() |
0.250 | ||